-
Teleflex On Accelerating Top-Line Growth Trajectory; Upgrading To Outperform
Friday, September 8, 2017 - 11:34am | 375Read More...Leerink Swann said in a note released on Thursday that it is increasingly confident in Teleflex Incorporated (NYSE: TFX)'s revenue growth acceleration trajectory. The firm attributed its increased confidence to the acquisition of Neotract the company announced on Sept. 5. Accordingly, the firm...
-
With Increasing Conviction In Intuitive Surgical, Analyst Sees 17% Upside From Here
Wednesday, July 5, 2017 - 11:48am | 600Read More...Leerink raised its price target for Intuitive Surgical, Inc. (NASDAQ: ISRG), following a thorough model review, which increased the firm's conviction on the company. The revised price target represents a 17-percent upside from current levels. An Aggressive View Analysts Richard Newitter and...
-
Intuitive Surgical's Q1 Gives This Already Bullish Analyst 'Even Higher Confidence'
Wednesday, April 19, 2017 - 2:50pm | 336Read More...Leerink said in a note Wednesday that Intuitive Surgical, Inc.'s (NASDAQ: ISRG) first quarter results give it even higher confidence in procedure growth trends. Leerink reiterated its Outperform rating and lifted its price target from $840 to $850, citing higher cash per share assumption....
-
Globus Medical Stands On The Brink Of Inflection; Leerink Upgrades
Wednesday, April 12, 2017 - 2:47pm | 373Read More...Considering Globus Medical Inc (NYSE: GMED) on the verge of significant revenue growth acceleration, Leerink Swann upgraded the musculoskeletal medical device company to Outperform and increased its price target from $29 to $40. The firm has been anticipating the ratings change since it downgraded...
